Expert consensus on the use of omalizumab in chronic urticaria in China
- Resource Type
- Review Article
- Authors
- Zhao, Zuotao; Cai, Tao; Chen, Hong; Chen, Liuqing; Chen, Yudi; Gao, Xiang; Gao, Xinghua; Geng, Songmei; Guo, Yinshi; Hao, Fei; Hao, Guodong; Hu, Yan; Jin, Hongzhong; Jin, Zhehu; Li, Chengxin; Li, Haili; Li, Jie; Li, Yanming; Liang, Yunsheng; Liu, Guanghui; Liu, Qiang; Long, Hai; Ma, Lin; Shang, Yuanyuan; Song, Yuxin; Song, Zhiqiang; Su, Xiangyang; Sui, Haijing; Sun, Qing; Sun, Yuemei; Tang, Jianping; Tong, Xunliang; Wang, Huiying; Wang, Gang; Wang, Lianglu; Wang, Siqin; Xiang, Li; Xiao, Ting; Xie, Zhiqiang; Ye, Leping; Yu, Yongmei; Zhang, Chunlei; Zhang, Litao; Zhang, Shuchen; Zheng, Rui; Zhi, Lili; Zhou, Wei; Zou, Ying; Maurer, Marcus
- Source
- In World Allergy Organization Journal November 2021 14(11)
- Subject
- Language
- ISSN
- 1939-4551